Full metadata record
DC FieldValueLanguage
dc.contributor.authorSultanova, Alina-
dc.contributor.authorCistjakovs, Maksims-
dc.contributor.authorSokolovska, Liba-
dc.contributor.authorTodorova, Katerina-
dc.contributor.authorCunskis, Egils-
dc.contributor.authorMurovska, Modra-
dc.date.accessioned2021-01-13T12:09:41Z-
dc.date.available2021-01-13T12:09:41Z-
dc.date.issued2020-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/2891-
dc.description.abstractThe aim of this study was to investigate the role of human herpesvirus-6 (HHV-6) in autoimmune thyroiditis (AIT) development. We examined the possible involvement of HHV-6 gene expression encoding immunomodulating proteins U12 and U51 in AIT development and their role in the modulation of chemokine signaling. One hundred patients with autoimmune thyroiditis following thyroidectomy were enrolled in this study. Nested polymerase chain reaction (nPCR) was used to detect the HHV-6 sequence in DNA samples. Reverse transcription PCR (RT-PCR) with three different HHV-6 gene targets (U79/80, U51 and U12) was to detect active infection markers. HHV-6 load was identified using a commercial real-time PCR kit. Immunohistochemistry was performed to investigate the expression of the HHV-6 antigen and RANTES (Regulated upon Activation, Normal T Cell Expressed and Secreted) in thyroid gland tissue. Different commercial immunosorbent assay kits were used for the detection of RANTES, IFNγ, IL-6, and TNFα levels in the AIT patient group and controls. We detected 98% presence of the HHV-6 genomic sequence in AIT patients’ thyroid gland tissues. Markers of active HHV-6 infection (HHV-6 U79/80, U12 and/or U51 mRNA) were predominant in AIT patients’ thyroid tissue samples in comparison with the control group (56% vs. 6%). Evidence from immunofluorescence microscopy showed that HHV-6 can persist in thyrocytes and can interact with RANTES. Visual confirmation of the intense immunofluorescence signal of RANTES detected in thyroid tissues could indicate high expression of this chemokine in the thyroid gland. On the other hand, immunosorbent assays showed very low RANTES levels in AIT patients’ peripheral plasma. These results indicate that RANTES level in AIT patients could be influenced by HHV-6 activation, which in turn may aid AIT developmenten_US
dc.language.isoenen_US
dc.relation.ispartofViruses 2020, 12(6), 689; https://doi.org/10.3390/v12060689en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectautoimmune thyroiditisen_US
dc.subjectHHV-6en_US
dc.subjectRANTESen_US
dc.subjectchemokine receptorsen_US
dc.titleHHV-6 Infection and Chemokine RANTES Signaling Pathway Disturbance in Patients with Autoimmune Thyroiditisen_US
dc.typeArticleen_US
Appears in Collections:Publications



This item is licensed under a Creative Commons License Creative Commons